What will treatment look like?
The purpose of this study is to understand the efficacy of a new form of cognitive behavioral therapy (CBT) that includes scenario rescripting. This treatment focuses on increasing empowerment and agency. In addition, all participants will be randomized to receive d-cycloserine or a placebo pill. D-cycloserine is an antibiotic
medication (prescribed in very low doses in the current study) that may enhance learning during therapy.
The CBT (therapy) sessions are conducted by qualified therapists. The treatment consists of 4 weekly sessions (2 hours each), as well as assigned activities in between sessions that offer the opportunity to solidify the knowledge learned in session on your own time. The sessions can be arranged at a time that is convenient for you.
The study consists of 5 weekly visits, plus two follow-up assessments that occur 1 week and 1 month after the end of the treatment. Each study visit will take up to two hours, and will take place in our clinic at Boston University.